TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06741527: Integrity Implant System Post Market Clinical Follow-Up Study

Sponsor: Anika Therapeutics, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 150 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$1,261,600

Rescue Site Savings

+$830,000

Unlock Full NCT06741527 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06741527 Rescue Dossier →